Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells

Published:2016-05 Issue: Volume:26 Page:28-42
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Xiong Xing-dong,Ren Xingcong,Cai Meng-yun,Yang Jay W.,Liu Xinguang,Yang Jin-Ming

Funder

National Natural Science Foundation of China

National Scholarship Fund of China

Natural Science Foundation of Guangdong Province

Foundation for Distinguished Talents in Higher Education of Guangdong

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference143 articles.

1. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression;Aguilo;Cancer Res.,2011

2. Molecular basis of antifolate resistance;Assaraf;Cancer Metastasis Rev.,2007

3. The folate receptor as a rational therapeutic target for personalized cancer treatment;Assaraf;Drug Resist. Updates,2014

4. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer;Augoff;Mol. Cancer,2012

5. MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas;Balik;J. Neurooncol.,2013

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting ferroptosis: a new therapeutic opportunity for kidney diseases;Frontiers in Immunology;2024-07-03

2. The Role and Therapeutic Potential of Non-coding RNAs in Resistance to EGFR-TKIs targeted therapy for Non-small Cell Lung Cancer;Current Medicinal Chemistry;2024-02-16

3. Long noncoding RNA H19: functions and mechanisms in regulating programmed cell death in cancer;Cell Death Discovery;2024-02-14

4. Multiple Sclerosis: Roles of miRNA, lcnRNA, and circRNA and Their Implications in Cellular Pathways;International Journal of Molecular Sciences;2024-02-13

5. Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy;Medical Oncology;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3